Related Expertise: Leadership Development, Public Sector, Health Care Payers, Providers, Systems & Services
Now more than ever, business and government have a crucial role to play in protecting people’s health, bolstering the economy, and developing both practical solutions and game-changing innovations. At BCG, we’re working with companies and public-sector organizations around the world to manage the impact of the coronavirus, with actions ranging from rapid responses to more fundamental, strategic shifts. We’re also helping leaders look much further ahead and envision how the crisis will continue to affect the competitive environment and what society will need in the coming months and years.
The rapid rise in COVID cases over the past few weeks has served as a painful reminder that the pandemic is far from over. Given its greater antibody resistance and high degree of transmissibility, the Delta variant is wreaking havoc across the globe, rivaling the devastation felt by the hardest hit areas in 2020. The good news, however, is that vaccines remain highly effective in combatting this new strain of the coronavirus. Accordingly, the public and private sectors still have significant roles to play in ensuring the continued creation and distribution of vaccines. Learn more in this special edition of BCG Executive Perspectives.
Already, we’ve seen major shifts that are forcing companies to rethink how they operate in virtually every area—from pricing and procurement to supply chains, sales, and cybersecurity. More change is sure to come.
These seven companies outperformed their industries during the pandemic—and in the process, they showed how businesses can turn crises into opportunities for growth.
Yesterday’s models can’t handle today’s challenges. Businesses won’t survive without a bold new approach for tomorrow.
Leaders now need to refocus on the long term and attend to five key imperatives.
Getting ready to contend with today’s disruptive forces is hard work, and most companies have a long way to go. But the juice is worth the squeeze.
Leading in the New Reality
What will the world look like after the pandemic? The answer is, in part, up to leaders in business and government around the world. They can shape our new reality.
No industry will be immune to the impact of COVID-19. For some, the crisis poses an existential threat. For all, now is the time to revisit basic assumptions about what it means to compete and thrive.
Our latest edition delves into the different ways the pandemic is affecting consumption habits and what this means for companies trying to keep up.
Global clusters of like-minded consumers are surprisingly rare. And even among countries with similar consumer attitudes, needs can differ sharply by product category.
As the pandemic hammered economies worldwide, these tech-enabled companies outperformed the market handily. What does their success reveal about future sources of growth and innovation?
Innovation is opening significant opportunities, but emboldened competitors are tightening the time frame for pursuing them.
The coronavirus crisis has created exceptional challenges for public sector organizations and health care companies while underscoring, for all industries, the power and importance of social impact.
BCG’s latest survey on the impact of COVID-19 shows which changes in how doctors engage with the pharma industry will last beyond the pandemic.
A new wave of innovation is coming. Pharma companies need to determine the role they will play in shaping it.
Concerns about Black hesitancy during the rollout of the COVID-19 vaccine have distracted health officials from the real issue: equitable access.
What has worked, what can be improved, and what needs to be reimagined so that we are better prepared for the next pandemic and better able to improve health in the world’s poorest nations?
Managing Director & Senior Partner, Chairman of the BCG Henderson Institute
San Francisco - Bay Area
